Abelzeta

Developer of T cell-based therapeutics for cancer and immunological diseases

placeRockville, Maryland, United States calendar_todayFounded 2009 language abelzeta.com

Innovation

16 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 1,400 times.

YearFilings
20202
20231
202410
202512
20265

Social engagement

Social engagement: 4K social following, 3 posts in the last 12 months — above the industry median.

Investor mix

2 investors on record.

Investor typeCountShare
Private equity150%
Bank & private debt150%

Recent activity

14 Jan 2026
Event
44th Annual J.P. Morgan Healthcare Conference
10 Oct 2025
Event
12th BioCentury-BayHelix China Healthcare Summit
Coming soon